R to @EU_Commission: Donors and recipients of substances of human origin, such as blood and cells, can continue to rely on safe medical products, treatments, and therapies.

We've adopted measures to prevent disruption in the supply of critical medicines and medical devices.

[2024-05-22 09:56 UTC]